Quarterly ResultMay 20, 2026, 04:37 PM
Cosmos Health Reports Q1 Net Loss $2.8M; Going Concern Doubt
AI Summary
Cosmos Health Inc. reported a net loss of $2.81 million for Q1 2026, significantly wider than the $0.82 million loss in Q1 2025, despite a 30.7% increase in revenue to $17.93 million. The company disclosed substantial doubt about its ability to continue as a going concern due to insufficient revenue to cover operating expenses and debt obligations, coupled with negative operating cash flow of $1.07 million. Management is pursuing strategies including product expansion, new distribution channels, and capital raises through an ATM program and convertible notes to address liquidity challenges.
Key Highlights
- Substantial doubt about Cosmos Health's ability to continue as a going concern for 12 months.
- Q1 2026 net loss widened to $2.81 million from $0.82 million in Q1 2025.
- Revenue increased 30.7% to $17.93 million in Q1 2026 from $13.71 million.
- Gross profit decreased to $1.38 million in Q1 2026 from $2.05 million in Q1 2025.
- Net cash used in operating activities increased to $1.07 million from $0.19 million.
- Raised $1.83 million through At-the-Market (ATM) program in Q1 2026.
- Secured a $300 million senior secured convertible promissory notes agreement.
- Stockholders' equity increased to $19.83 million from $18.42 million as of December 31, 2025.
Price Impact
More from COSM